Phase 1 Drug Candidate GLR2007 Developed by Gan Lee has been...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BEIJING and BRIDGEWATER, N.J., Jan. 30, 2021 /PRNewswire-AsiaNet/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (Shanghai: 603087.SH), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for GLR2007, ...
Authors: LATEST ASIANET NEWS RELEASES